Since potent humoral responses have been shown to be a strong correlate of vaccine effectiveness and protection against COVID-19, we first analyzed mucosal and systemic IgG and IgA responses in mice vaccinated with spike and RBD adjuvanted with either CT or AMVAD. Here, CD79A is linked to COVID-19.